• Cy7 NHS Ester: Practical Protein Labeling Guide

  2026-08-11

  Cy7 NHS ester (SKU A8109) is a water-soluble, sulfonated near-infrared dye for bioimaging and amino-group labeling of proteins and peptides. It is useful when organic cosolvents could compromise a delicate biomolecule, but working solutions should be prepared promptly and the reagent should not be selected when long-term solution storage or unvalidated in vivo performance is required.

• l-Phe Nanostructures Sensitize Tumors to ICB

  2026-08-11

  This Nature Nanotechnology study shows that metal-ion-chelating l-phenylalanine nanostructures can remodel immune dysfunction by regulating dendritic-cell electrophysiology, inflammasome activity, and NF-κB signaling. When combined with short-term starvation, the nanostructures enhanced dendritic-cell maturation and tumor-specific cytotoxic T-cell responses, thereby sensitizing breast and colorectal tumors to immune checkpoint blockade.

• Gemcitabine Beyond Cytotoxicity: A DDR Strategy

  2026-08-10

  A mechanism-first guide to positioning Gemcitabine in translational cancer research, connecting replication-stress biology, checkpoint signaling, apoptosis assays, and insights from lycorine-driven metabolic research.

• Sulfo-NHS-Biotin Maps CADASIL Vascular Signaling

  2026-08-09

  The NOTCH3 R545C CADASIL model links vascular injury to blood-brain barrier disruption, neuroinflammation, and impaired hippocampal plasticity. This thought-leadership article explains how Sulfo-NHS-Biotin can help translational researchers convert those findings into testable cell-surface proteome and protein-interaction studies while preserving the distinction between mechanistic evidence and workflow opportunity.

• JC-1 and the Next Layer of Tumor Immunity

  2026-08-08

  A translational framework for using mitochondrial membrane potential as a mechanistic bridge between redox-driven tumor immunomodulation, apoptosis biology, and development decisions.

• Biotin-HPDP for Palmitoylation Assays

  2026-08-07

  Biotin-HPDP enables reversible thiol-specific labeling for affinity enrichment and modification analysis. This article develops an assay decision framework linking its chemistry to CD36 palmitoylation, microglial biology, and S-nitrosylation research.

• NHS-Biotin: Precision Biotinylation for Protein Engineering

  2026-08-07

  NHS-Biotin (N-hydroxysuccinimido biotin) enables rapid, stable, and site-specific labeling of antibodies and proteins, unlocking advanced workflows for detection, purification, and multimeric nanobody assembly. Its unique membrane-permeability and short spacer arm make it ideal for both intracellular and extracellular protein engineering, as demonstrated by recent innovations in peptidisc-assisted nanobody clustering.

• GI 254023X: Precision ADAM10 Inhibitor for Vascular Models

  2026-08-06

  GI 254023X sets a new standard for selective ADAM10 inhibition, enabling researchers to dissect cell signaling, apoptosis, and vascular integrity with nanomolar precision. Its robust selectivity profile and proven efficacy in endothelial and immune models make it a preferred tool for preclinical exploration of ADAM10-mediated pathways.

• N-Glycosylation of Fzd4 Is Critical for Wnt/β-Catenin Signal

  2026-08-06

  This study identifies two highly conserved N-glycosylation sites on the Frizzled-4 (Fzd4) receptor that are essential for its maturation, stability, and function within the Wnt/β-catenin signaling pathway. Loss of these glycosylation modifications disrupts Fzd4 trafficking and impedes non-small cell lung cancer (NSCLC) growth, offering new mechanistic insight and therapeutic targets.

• Toremifene as a SERM Tool: Advanced Strategies for Prostate

  2026-08-05

  Explore how Toremifene, a selective estrogen-receptor modulator, is transforming prostate cancer research with its precise mechanism and assay optimization. This article uncovers actionable insights and novel applications that go beyond standard SERM approaches.

• Gap26: Elevating Translational Science in Connexin 43 Resear

  2026-08-05

  Explore how Gap26, a selective connexin 43 mimetic peptide, is redefining translational research by enabling mechanistic insights into gap junction biology, optimizing protocols for mitochondrial transfer and calcium signaling, and setting new standards in vascular and neuroprotection studies. This article bridges cutting-edge findings with actionable guidance, highlighting the strategic value of APExBIO’s Gap26 for researchers aiming to unravel complex intercellular communication and advance disease modeling.

• Redefining Cell Surface Interactomes: Sulfo-NHS-SS-Biotin in

  2026-08-04

  This thought-leadership article explores how Sulfo-NHS-SS-Biotin enables a new era of reversible, selective cell surface labeling—bridging recent discoveries in glycoRNA–protein domains with advanced translational workflows. We synthesize mechanistic insights, competitive positioning, and strategic protocol guidance to empower translational researchers in mapping, purifying, and interrogating the cell surface interactome.

• NHS-Biotin (A8002): Transforming Multimeric Protein Analysis

  2026-08-04

  Explore how NHS-Biotin (N-hydroxysuccinimido biotin) is revolutionizing multimeric protein engineering and detection. This in-depth article reveals unique insights into its mechanistic advantages, practical applications, and recent scientific breakthroughs.

• Cy7 NHS Ester: Protocols and QC for Near-Infrared Protein La

  2026-08-03

  Cy7 NHS ester (Sulfo-Cy7 NHS Ester) is a hydrophilic, sulfonated near-infrared dye optimized for labeling biomolecules such as proteins and peptides via accessible amino groups. It solves challenges related to protein denaturation and fluorescence quenching in aqueous, delicate systems. However, it is not suitable for labeling biomolecules lacking primary amines or for workflows requiring long-term storage of dye solutions.

• NOTCH3 R545C Mutation Drives Vascular-Neuronal Dysfunction i

  2026-08-03

  This study introduces a CRISPR/Cas9-engineered mouse model carrying the NOTCH3 R545C mutation, orthologous to the common human R544C variant seen in CADASIL. Through integrated behavioral, histological, and transcriptomic approaches, the paper uncovers how this mutation initiates age-dependent cognitive decline, vascular pathology, and neuroinflammation, providing a robust platform for dissecting CADASIL pathogenesis and potential therapeutic targets.

16884 records 1/1126 page Next 12345 下5页 Last page